https://kitherbiotech.com/kither-biotech-raises-a-e5-6m-financing-round-to-support-the-clinical-development-of-a-new-drug-for-cystic-fibrosis-and-other-pulmonary-diseases/ 2025-06-13T10:30:00+00:00 https://kitherbiotech.com/kither-biotech-raises-e18-5-million-series-b-and-appoints-dr-vincent-metzler-as-chief-executive-officer/ 2025-06-13T10:30:51+00:00 https://kitherbiotech.com/kither-biotech-announces-publication-of-new-data-in-science-translational-medicine/ 2025-06-13T10:34:13+00:00 https://kitherbiotech.com/kither-biotech-announces-appointment-of-dr-dimitrios-goundis-to-board-of-directors/ 2025-06-13T10:34:15+00:00 https://kitherbiotech.com/kither-biotech-announces-phase-1-clinical-study-of-kit2014-a-novel-inhaled-peptide-therapy-for-cystic-fibrosis/ 2025-06-13T10:34:19+00:00 https://kitherbiotech.com/kither-biotech-and-pantherna-therapeutics-announce-strategic-collaboration-on-synergistic-mrna-and-peptide-therapies-for-genetic-lung-diseases/ 2026-06-03T15:11:34+00:00 https://kitherbiotech.com/kither-biotech-successfully-completes-phase-1-clinical-trial-of-kit2014-a-novel-inhaled-peptide-therapy-for-respiratory-diseases/ 2026-06-19T11:06:42+00:00